Newsmakers

Newsmakers

Manuscript Describes How CytoDyn’s (OTC: CYDY) Leronlimab Disrupts CCL5/RANTES-CCR5 Pathway, Thereby Restoring Immune Homeostasis, Reducing Plasma Viral Load, Reversing Hyper Immune Activation and Inflammation in Critical COVID-19 Patients

May 6, 2020 admin Comments Off on Manuscript Describes How CytoDyn’s (OTC: CYDY) Leronlimab Disrupts CCL5/RANTES-CCR5 Pathway, Thereby Restoring Immune Homeostasis, Reducing Plasma Viral Load, Reversing Hyper Immune Activation and Inflammation in Critical COVID-19 Patients

VANCOUVER, Washington, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) — Manuscript Posted Online to Research Square and MedRxiv Pre-print Server CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO […]

Healthcare

Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn (OTC: CYDY) for Drug Product Used in COVID-19 Clinical Trials

May 5, 2020 admin Comments Off on Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn (OTC: CYDY) for Drug Product Used in COVID-19 Clinical Trials

SAN DIEGO, May 5, 2020  —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]

Newsmakers

fuboTV Announces Ticker Symbol Change To (OTC: FUBO)

May 1, 2020 admin Comments Off on fuboTV Announces Ticker Symbol Change To (OTC: FUBO)

FaceBank Group, Inc. (d/b/a fuboTV) announced today that the company’s ticker symbol on the OTCQB has changed to “FUBO” from “FBNK” effective tomorrow at market open. The number of shares outstanding of the registrant’s common […]

Healthcare

CytoDyn (OTC: CYDY) Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

April 30, 2020 admin Comments Off on CytoDyn (OTC: CYDY) Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]

Newsmakers

NexTech AR (OTC: NEXCF) Acquires Work From Home (WFH) Virtual Events Webcasting Live Streaming Software Company Jolokia

April 30, 2020 admin Comments Off on NexTech AR (OTC: NEXCF) Acquires Work From Home (WFH) Virtual Events Webcasting Live Streaming Software Company Jolokia

The combined companies launching AR first Virtual Conferences NEW YORK and TORONTO, April 30, Apr 30, 2020 — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a leader in augmented reality for eCommerce […]

Newsmakers

fuboTV (OTC: FBNK) CEO David Gandler Featured by Wedbush Securities Managing Director of Digital Media Equity Research Michael Pachter in Public Company Spotlight

April 29, 2020 admin Comments Off on fuboTV (OTC: FBNK) CEO David Gandler Featured by Wedbush Securities Managing Director of Digital Media Equity Research Michael Pachter in Public Company Spotlight

FaceBank Group, Inc. d/b/a fuboTV [OTCQB:FBNK] CEO David Gandler was featured in a discussion led by Michael Pachter, Managing Director of Digital Media Equity Research at Wedbush Securities, to dive deeper into trends around cord-cutting, […]

Newsmakers

ImagineAR (OTC: IPNFF) Signs Five Year $300,000USD Licensing Agreement with SlapItOn to Provide Augmented Reality for Athletes and Celebrities to Engage Fans

April 29, 2020 admin Comments Off on ImagineAR (OTC: IPNFF) Signs Five Year $300,000USD Licensing Agreement with SlapItOn to Provide Augmented Reality for Athletes and Celebrities to Engage Fans

Contract Revenue is $300,000USD Plus 5 Year Management Program Revenue Fees VANCOUVER and ERIE, PA, April 29, 2020  – Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) (“ImagineAR” or “Company”) is pleased to announce the signing of a […]

Healthcare

CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

April 27, 2020 admin Comments Off on CytoDyn (OTC: CYDY) Announces Vyrologix as Proprietary Name for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients in the United States

Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]

Healthcare

CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients

April 27, 2020 admin Comments Off on CytoDyn (OTC: CYDY) Submits Completed Biologics License Application (BLA) to the FDA for Leronlimab as a Combination Therapy for Highly Treatment Experienced HIV Patients

VANCOUVER, Washington, Apr 27, 2020  — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]

Newsmakers

CytoDyn to Hold Conference Call to Provide Updates on Completion of BLA Filing for HIV, Timeline for Potential Approval of Treatment for COVID-19 Patients, and Two Publications, Including The New England Journal of Medicine

April 24, 2020 admin Comments Off on CytoDyn to Hold Conference Call to Provide Updates on Completion of BLA Filing for HIV, Timeline for Potential Approval of Treatment for COVID-19 Patients, and Two Publications, Including The New England Journal of Medicine

VANCOUVER, Washington, Apr 24, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]

Newsmakers

NexTech AR (OTC: NEXCF) Provides Update on Acquisition of Work From Home (WFH) Virtual Events Webcasting Software Company Jolokia Published: April 23, 2020 at 8:30 a.m. ET

April 23, 2020 admin Comments Off on NexTech AR (OTC: NEXCF) Provides Update on Acquisition of Work From Home (WFH) Virtual Events Webcasting Software Company Jolokia Published: April 23, 2020 at 8:30 a.m. ET

NEW YORK and TORONTO, April 23, Apr 23, 2020 — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), the leader in augmented reality for eCommerce and AR learning applications, is pleased to update […]